Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Findling

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Stroke|May 7, 2011
Three-month and long-term outcomes and their predictors in acute basilar artery occlusion treated with intra-arterial thrombolysisSimon Jung, Marie-Luise Mono, Urs Fischer, et al.
Neurology|March 8, 2013
Copeptin adds prognostic information after ischemic stroke: results from the CoRisk studyGian Marco De Marchis, Mira Katan, Anja Weck, et al.
Journal of Neurology|May 10, 2012
Atorvastatin added to interferon β for relapsing multiple sclerosis: a randomized controlled trialChristian Philipp Kamm, Marwan El-Koussy, Sebastian Humpert, et al.
Neurology|March 3, 2019
A novel biomarker-based prognostic score in acute ischemic stroke: The CoRisk scoreGian Marco De Marchis, Theresa Dankowski, Inke R König, et al.
Stroke|March 10, 2012
Impact of thrombolysis on stroke outcome at 12 months in a population: the Bern stroke projectUrs Fischer, Marie-Luise Mono, Marcel Zwahlen, et al.
Plos One|April 1, 2016
The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment OptionsGiulio Disanto, Pascal Benkert, Johannes Lorscheider, et al.
Trials|September 11, 2024
MultiSCRIPT-Cycle 1-a pragmatic trial embedded within the Swiss Multiple Sclerosis Cohort (SMSC) on neurofilament light chain monitoring to inform personalized treatment decisions in multiple sclerosis: a study protocol for a randomized clinical trialPerrine Janiaud, Chiara Zecca, Anke Salmen, et al.
Annals of Neurology|May 31, 2021
Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple SclerosisJohanna Oechtering, Sabine Schaedelin, Pascal Benkert, et al.
Journal of Magnetic Resonance Imaging : JMRI|January 28, 2023
A Multicenter Longitudinal MRI Study Assessing LeMan-PV Software Accuracy in the Detection of White Matter Lesions in Multiple Sclerosis PatientsAlexandra Ramona Todea, Lester Melie-Garcia, Muhamed Barakovic, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 29, 2025
Personalized treatment decision algorithms for the clinical application of serum neurofilament light chain in multiple sclerosis: A modified Delphi StudyÖzgür Yaldizli, Pascal Benkert, Lutz Achtnichts, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Stroke|May 7, 2011
Three-month and long-term outcomes and their predictors in acute basilar artery occlusion treated with intra-arterial thrombolysisSimon Jung, Marie-Luise Mono, Urs Fischer, et al.
Neurology|March 8, 2013
Copeptin adds prognostic information after ischemic stroke: results from the CoRisk studyGian Marco De Marchis, Mira Katan, Anja Weck, et al.
Journal of Neurology|May 10, 2012
Atorvastatin added to interferon β for relapsing multiple sclerosis: a randomized controlled trialChristian Philipp Kamm, Marwan El-Koussy, Sebastian Humpert, et al.
Neurology|March 3, 2019
A novel biomarker-based prognostic score in acute ischemic stroke: The CoRisk scoreGian Marco De Marchis, Theresa Dankowski, Inke R König, et al.
Stroke|March 10, 2012
Impact of thrombolysis on stroke outcome at 12 months in a population: the Bern stroke projectUrs Fischer, Marie-Luise Mono, Marcel Zwahlen, et al.
Plos One|April 1, 2016
The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment OptionsGiulio Disanto, Pascal Benkert, Johannes Lorscheider, et al.
Trials|September 11, 2024
MultiSCRIPT-Cycle 1-a pragmatic trial embedded within the Swiss Multiple Sclerosis Cohort (SMSC) on neurofilament light chain monitoring to inform personalized treatment decisions in multiple sclerosis: a study protocol for a randomized clinical trialPerrine Janiaud, Chiara Zecca, Anke Salmen, et al.
Annals of Neurology|May 31, 2021
Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple SclerosisJohanna Oechtering, Sabine Schaedelin, Pascal Benkert, et al.
Journal of Magnetic Resonance Imaging : JMRI|January 28, 2023
A Multicenter Longitudinal MRI Study Assessing LeMan-PV Software Accuracy in the Detection of White Matter Lesions in Multiple Sclerosis PatientsAlexandra Ramona Todea, Lester Melie-Garcia, Muhamed Barakovic, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 29, 2025
Personalized treatment decision algorithms for the clinical application of serum neurofilament light chain in multiple sclerosis: A modified Delphi StudyÖzgür Yaldizli, Pascal Benkert, Lutz Achtnichts, et al.
Pageof 6